Founding Governing Board Members of ISPMP. Favia, University of Bari, Italy
K-D. Weltmann, Leibniz Institute for Plasma Science and Technology, Greifswald, Germany
M. Laroussi, Old Dominion University, USA
M. Wertheimer, Montreal University, Canada
M. G. Kong, Loughborough University, Loughborough,UK
S. Hamaguchi, Osaka University, Osaka, Japan,
G. Friedman, Drexel University, Philadelphia, PA USA
J-M. Pouvesle, University of Orleans, Orleans, France
D. Graves, University of California, Berkley, CA USA
R. Satava, University of Washington, Seattle, WA USA
G. Morfill, Max Plank Institute, Munich, Germany
G. Lloyd, Linde Group, London, England, UK
A. Fridman, Drexel University, Philadelphia, PA, USA
F. Arefi-Khonsari, Ecole de Chimie, Universite’ Pierre et Marie Curie, France
A. Dolgopolsky, Drexel University, Philadelphia, PA, USA
Founding Officers of ISPMPresident: Alex Fridman, PhD
Vice President: K-D. Weltmann, PhD
Treasurer: Alex Dolgopolsky, PhD
Secretary: Gary Friedman, PhD
The A. J. Drexel Plasma Institute recently hosted
the 2nd International Conference on Plasma Medicine (ICPM-2) in San Antonio
Texas on March 16th - 20th, 2009. Of the 150 participants, 14 countries were
represented to include France, Germany, the Netherlands, Canada, Japan, and
South Korea. The 1st International Conference on Plasma Medicine (ICPM-1) was a
great success, as can be seen from the special issue
on plasma medicine consisting of selected contributions from conference
participants. This year’s conference saw an increase in the amount of
contributing attendees, as well as the establishment of the International
Society on Plasma Medicine (ISPM). Prof. Alexander Fridman has been elected as
the president of ISPM. Contributions from 19 Drexel affiliates were
represented, to include four MEM faculty and four MEM students.
The reins of the
conference were given to Dr. Klaus-Dieter Weltmann, Director of the Leibniz
Institute for Plasma Science, and the host for ICPM-3. With ICPM-3 set to occur
in Greifswald and future plans to host in South Korea and France, the
international conference is increasing it’s scope and visibility throughout the
world and continues to advance the field of plasma medicine.
[article from Drexel's MEM news]
Corporate Council:
